AR033596A1 - PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTION CONTAINING LOXOPROPHENE - Google Patents

PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTION CONTAINING LOXOPROPHENE

Info

Publication number
AR033596A1
AR033596A1 ARP010105804A ARP010105804A AR033596A1 AR 033596 A1 AR033596 A1 AR 033596A1 AR P010105804 A ARP010105804 A AR P010105804A AR P010105804 A ARP010105804 A AR P010105804A AR 033596 A1 AR033596 A1 AR 033596A1
Authority
AR
Argentina
Prior art keywords
intramuscular injection
loxoprophene
pharmaceutical composition
injection containing
formulation
Prior art date
Application number
ARP010105804A
Other languages
Spanish (es)
Original Assignee
Shin Poong Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shin Poong Pharmaceutical Co filed Critical Shin Poong Pharmaceutical Co
Publication of AR033596A1 publication Critical patent/AR033596A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una formulacion para inyeccion intramuscular, la cual contiene loxoprofeno o una sal farmacéuticamente aceptable del mismo, que presenta un excelente efecto analgésico antiinflamatorio, como ingrediente activoA formulation for intramuscular injection, which contains loxoprofen or a pharmaceutically acceptable salt thereof, which has an excellent anti-inflammatory analgesic effect, as an active ingredient.

ARP010105804A 2000-12-14 2001-12-14 PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTION CONTAINING LOXOPROPHENE AR033596A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2000-0076298A KR100405161B1 (en) 2000-12-14 2000-12-14 Pharmaceutical composition for intramuscular injection containing loxoprofen

Publications (1)

Publication Number Publication Date
AR033596A1 true AR033596A1 (en) 2003-12-26

Family

ID=36691545

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010105804A AR033596A1 (en) 2000-12-14 2001-12-14 PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTION CONTAINING LOXOPROPHENE

Country Status (12)

Country Link
JP (1) JP2004515526A (en)
KR (1) KR100405161B1 (en)
CN (1) CN1278672C (en)
AP (1) AP1530A (en)
AR (1) AR033596A1 (en)
AU (1) AU2002222750A1 (en)
BR (1) BR0108313A (en)
MX (1) MXPA02007788A (en)
OA (1) OA12175A (en)
RU (1) RU2232572C2 (en)
UA (1) UA76097C2 (en)
WO (1) WO2002047661A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040054008A1 (en) 2002-09-13 2004-03-18 Tohru Araki Medicament for treatment of nocturia
EP2368554B1 (en) 2003-04-08 2014-12-24 Progenics Pharmaceuticals, Inc. Pharmaceutical formulations containing methylnaltrexone
ES2439497T3 (en) 2007-09-04 2014-01-23 Meiji Seika Pharma Co., Ltd. Preparation of an injection, an injection solution and an injection kit
EP2243477A1 (en) * 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol for parenteral application
JP2011225514A (en) * 2009-10-30 2011-11-10 Kowa Co Pharmaceutical composition containing loxoprofen or salt thereof
EP2926832A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical formulations of loxoprofen for topical use
EP2926810A1 (en) 2014-03-31 2015-10-07 Sanovel Ilac Sanayi ve Ticaret A.S. Oral liquid pharmaceutical formulations of loxoprofen
WO2015165847A1 (en) 2014-04-29 2015-11-05 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical formulations of loxoprofen
EP3160507A1 (en) 2014-06-30 2017-05-03 Sanovel Ilac Sanayi ve Ticaret A.S. Loxoprofen and gamma-aminobutiric acid receptor agonist combinations
WO2016046189A1 (en) 2014-09-24 2016-03-31 Sanovel Ilac Sanayi Ve Ticaret A.S. Loxoprofen and antispastic drug combinations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747535B2 (en) * 1985-11-26 1995-05-24 日東電工株式会社 Anti-inflammatory analgesic patch
JPH10120560A (en) * 1996-08-26 1998-05-12 Sankyo Co Ltd Loxoprofen-containing preparation for external use
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy

Also Published As

Publication number Publication date
WO2002047661A1 (en) 2002-06-20
KR100405161B1 (en) 2003-11-12
RU2232572C2 (en) 2004-07-20
UA76097C2 (en) 2006-07-17
CN1278672C (en) 2006-10-11
OA12175A (en) 2006-05-09
KR20020046407A (en) 2002-06-21
AP2002002594A0 (en) 2002-09-30
CN1400892A (en) 2003-03-05
BR0108313A (en) 2003-03-11
AP1530A (en) 2006-01-04
AU2002222750A1 (en) 2002-06-24
JP2004515526A (en) 2004-05-27
MXPA02007788A (en) 2002-10-17

Similar Documents

Publication Publication Date Title
AR033423A1 (en) PHARMACEUTICAL SALTS CONSTITUTED OF AN ACTIVE PHARMACEUTICAL SUBSTANCE AND AT LEAST A SWEETENER, MEDICATIONS CONTAINING THESE SALTS AND USE OF THESE SALTS FOR THE PREPARATION OF MEDICINES
HN2001000224A (en) IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI - INFLAMMATORY AND ANALGESIC AGENTS.
CO5580767A2 (en) INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES AND PROCEDURES FOR USE
ES2088312T3 (en) CONTROLLED RELEASE FORMULATION CONTAINING TRAMADOL.
CL2011000170A1 (en) Solid and stabilized pharmaceutical composition comprising a pharmaceutically active ingredient, titanium oxide and a plasticizer; procedure to stabilize the pharmaceutical composition during a light irradiation.
AR059357A1 (en) PHARMACEUTICAL FORMULATIONS
CO6331425A2 (en) COMPOSITIONS THAT INCLUDE N- (3,4-DIFLUORO-2- (2-FLUORO-4-IODOFENILAMINO) 6-METOXIFENIL) -1- (2,3-DIHYDROXIPROXIPROPIL) CICLOPROPAN-1-SULFAMIDA
AR038527A1 (en) DOSAGE FORM CONTAINING A PDE 4 INHIBITOR AS ACTIVE INGREDIENT
BRPI0507897B8 (en) solid drug formulation
ECSP10010224A (en) LUTEINIZING HORMONE LIQUID FORMULATIONS (LH).
MXPA06011467A (en) Active substance combination comprising a carbinol combined to at least an nsaid.
AR059359A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING PLECONARIL
GT200600163A (en) NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION
PE20150773A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF PHENYLEPHRINE
ES2192234T3 (en) PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING SALTS OF 2-ARILPROPIONIC ACIDS.
AR043423A1 (en) CONTROLLED RELEASE SYSTEM
NO20081038L (en) Pharmaceutical formulations / compositions of guanfacine suitable for daily single dosage form administration
CL2007001752A1 (en) Compound 4- [5 (2-amino-ethanesulfonyl) -isoquinolin-7-yl] -phenolo a pharmaceutically acceptable salt or a hydrate or salt thereof; pharmaceutical composition comprising said compound, lyophilized pharmaceutical composition; and use of the compound as antineiplasic and / or antiviral.
ECSP045493A (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLIBANSERINE POLYMORPH A
AR033596A1 (en) PHARMACEUTICAL COMPOSITION FOR INTRAMUSCULAR INJECTION CONTAINING LOXOPROPHENE
NO20064808L (en) Oral matrix formulations with licarbazepine
AR034813A1 (en) PHARMACEUTICAL COMPOSITIONS AND USE OF THE SAME
CL2004001843A1 (en) COMBINATION OF (A) AT LEAST A 2,5-DIHYDROBENCENOSULPHONIC DERIVATIVE, AS CALCIUM DOBEYLATE, ETHAMSYLATE AND PERSILATE, AND (B) AT LEAST A MODULATOR OF POTASSIUM CHANNELS, PHARMACEUTICAL COMPOSITION CONTAINING AND USE AS A MEDICATION IN PROFILA
ES2150404T3 (en) PHARMACEUTICAL COMPOSITIONS OF TIZOXANIDA AND NITOZOXANIDA.
ATE460934T1 (en) PHARMACEUTICAL PREPARATIONS OF CIPROFLOXACIN

Legal Events

Date Code Title Description
FB Suspension of granting procedure